These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

994 related items for PubMed ID: 17381663

  • 1. Management of drug-interaction alerts in community pharmacies.
    Indermitte J, Beutler M, Bruppacher R, Meier CR, Hersberger KE.
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and patient awareness of selected potential drug interactions with self-medication.
    Indermitte J, Reber D, Beutler M, Bruppacher R, Hersberger KE.
    J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
    [Abstract] [Full Text] [Related]

  • 3. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
    Halkin H, Katzir I, Kurman I, Jan J, Malkin BB.
    Clin Pharmacol Ther; 2001 Apr; 69(4):260-5. PubMed ID: 11309555
    [Abstract] [Full Text] [Related]

  • 4. Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies.
    Buurma H, Schalekamp T, Egberts AC, De Smet PA.
    Ann Pharmacother; 2007 Dec; 41(12):2024-31. PubMed ID: 17971404
    [Abstract] [Full Text] [Related]

  • 5. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, Rehfeld RA, Woosley RL.
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [Abstract] [Full Text] [Related]

  • 6. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS.
    Arch Intern Med; 2003 Nov 24; 163(21):2625-31. PubMed ID: 14638563
    [Abstract] [Full Text] [Related]

  • 7. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A, Griese N, Schulz M.
    Ann Pharmacother; 2007 Nov 24; 41(11):1825-32. PubMed ID: 17925500
    [Abstract] [Full Text] [Related]

  • 8. Overrides of medication alerts in ambulatory care.
    Isaac T, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, Weingart SN.
    Arch Intern Med; 2009 Feb 09; 169(3):305-11. PubMed ID: 19204222
    [Abstract] [Full Text] [Related]

  • 9. Assessing the value of electronic prescribing in ambulatory care: a focus group study.
    Weingart SN, Massagli M, Cyrulik A, Isaac T, Morway L, Sands DZ, Weissman JS.
    Int J Med Inform; 2009 Sep 09; 78(9):571-8. PubMed ID: 19395307
    [Abstract] [Full Text] [Related]

  • 10. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H, Mulder A, van Gelder T, Aarts J, Berg M, Vulto A.
    Pharmacoepidemiol Drug Saf; 2009 Oct 09; 18(10):941-7. PubMed ID: 19579216
    [Abstract] [Full Text] [Related]

  • 11. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.
    Becker ML, Caspers PW, Kallewaard M, Bruinink RJ, Kylstra NB, Heisterkamp S, de Valk V, van der Veen AA, Stricker BH.
    Pharm World Sci; 2007 Apr 09; 29(2):51-7. PubMed ID: 17187223
    [Abstract] [Full Text] [Related]

  • 12. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
    Hines LE, Saverno KR, Warholak TL, Taylor A, Grizzle AJ, Murphy JE, Malone DC.
    Res Social Adm Pharm; 2011 Dec 09; 7(4):359-68. PubMed ID: 21530417
    [Abstract] [Full Text] [Related]

  • 13. Potential drug interactions and duplicate prescriptions among cancer patients.
    Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK.
    J Natl Cancer Inst; 2007 Apr 18; 99(8):592-600. PubMed ID: 17440160
    [Abstract] [Full Text] [Related]

  • 14. Drug related problems identified by European community pharmacists in patients discharged from hospital.
    Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H, ESCP-SIR Rejkjavik Community Pharmacy Research Group.
    Pharm World Sci; 2004 Dec 18; 26(6):353-60. PubMed ID: 15683106
    [Abstract] [Full Text] [Related]

  • 15. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I, Horn AM, Ekedahl A, Granas AG.
    Res Social Adm Pharm; 2010 Mar 18; 6(1):6-17. PubMed ID: 20188324
    [Abstract] [Full Text] [Related]

  • 16. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
    Buurma H, De Smet PA, Egberts AC.
    Drug Saf; 2006 Mar 18; 29(8):723-32. PubMed ID: 16872246
    [Abstract] [Full Text] [Related]

  • 17. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J, Taylor SJ.
    Rural Remote Health; 2007 Mar 18; 7(3):743. PubMed ID: 17688377
    [Abstract] [Full Text] [Related]

  • 18. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ, Mahmood MH, Ko Y, Murphy JE, Armstrong EP, Skrepnek GH, Jones WN, Schepers GP, Nichol WP, Houranieh A, Dare DC, Hoey CT, Malone DC.
    Am J Manag Care; 2007 Oct 18; 13(10):573-8. PubMed ID: 17927462
    [Abstract] [Full Text] [Related]

  • 19. An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care.
    Weingart SN, Simchowitz B, Padolsky H, Isaac T, Seger AC, Massagli M, Davis RB, Weissman JS.
    Arch Intern Med; 2009 Sep 14; 169(16):1465-73. PubMed ID: 19752403
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the clinical value of pharmacists' modifications of prescription errors.
    Buurma H, De Smet PA, Leufkens HG, Egberts AC.
    Br J Clin Pharmacol; 2004 Nov 14; 58(5):503-11. PubMed ID: 15521898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.